NATUS MEDICAL INCORPORATED

(NTUS)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
32.65 USD   +1.15%
06/15NATUS MEDICAL INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
05/17NATUS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA : Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS
BU
05/06NATUS MEDICAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SHAREHOLDER ALERT: Weiss Law Investigates Natus Medical Incorporated

04/18/2022 | 06:20pm EDT

NEW YORK, April 18, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Natus Medical Incorporated ("Natus" or the "Company") (NASDAQ: NTUS), in connection with the proposed acquisition of the Company by an affiliate of ArchiMed. Under the terms of the merger agreement, the Company's shareholders will receive $33.50 in cash for each share of Natus common stock owned. The transaction is valued at $1.2 billion.

If you own Natus shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:
https://www.weisslaw.co/news-and-cases/ntus 
Or please contact:
Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Weiss Law is investigating whether (i) Natus's board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $33.50 per-share merger consideration adequately compensates Natus's shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.

Weiss Law has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-investigates-natus-medical-incorporated-301527357.html

SOURCE Weiss Law


© PRNewswire 2022
All news about NATUS MEDICAL INCORPORATED
06/15NATUS MEDICAL INC : Submission of Matters to a Vote of Security Holders, Financial Stateme..
AQ
05/17NATUS MEDICAL INVESTOR ALERT BY THE : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
05/06NATUS MEDICAL INC Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/05NATUS MEDICAL INVESTOR ALERT BY THE : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
05/05NATUS MEDICAL : Q1 Earnings Snapshot
AQ
05/05Earnings Flash (NTUS) NATUS MEDICAL INCORPORATED Reports Q1 EPS $0.22, vs. Street Est o..
MT
05/05Natus Medical Q1 Non-GAAP EPS, Revenue Rise
MT
05/05Natus Medical Incorporated Reports Earnings Results for the First Quarter Ended March 3..
CI
05/05Natus Medical Announces First Quarter 2022 Financial Results
AQ
04/19CORRECTION : Sector Update: Health Care Stocks Stumble Monday Afternoon
MT
More news